The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Reardon William S since year 2005.
The trader's CIK number is 1212646.
At the time of this reporting, Reardon William S is the Director of H&q Life Sciences Investors .
(stock ticker symbol HQL).
See this page for all insider trading activities at H&q Life Sciences Investors .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2014-06-30||HQL||H&q Life Sciences Investors||Buy||200||19.75||3,950|
|2013-11-13||SNTA||Synta Pharmaceuticals Corp||Buy||13,333||3.75||49,998|
|2012-03-09||HQH||H&q Healthcare Investors||Buy||646||15.86||10,242|
|2012-03-09||HQL||H&q Life Sciences Investors||Buy||772||13.27||10,241|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Reardon William S (Director of H&q Life Sciences Investors at the time of this reporting) see the Securities and Exchange Commission (SEC) website.